{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "SNCA A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The classic manifestation of familial and sporadic PD is the formation of fibrillar structures of RS, which accumulate as the main component in intraneuronal Lewy bodies.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly defines the disease mechanism as RS misfolding and aggregation into fibrillar structures (Lewy bodies), which is central to PD pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses solution NMR to analyze phospholipid binding modes of RS variants, which relate to their role in membrane interactions and potential misfolding.",
          "judgment": "Yes",
          "reasoning": "Phospholipid binding is a key functional domain of RS, and its disruption is directly linked to disease mechanisms (e.g., altered membrane interactions and aggregation).",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The study compares variants to wild-type RS and references previous biophysical studies, indicating controls were used.",
          "judgment": "No",
          "reasoning": "The paper does not explicitly state if multiple replicates were performed or if known pathogenic/benign variants (outside wild-type) were used as controls.",
          "next_step_or_outcome": "Proceed to Sub-step 3b"
        },
        {
          "step_name": "Sub-step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "Solution NMR is a standard technique in structural biology for characterizing protein-lipid interactions.",
          "judgment": "Yes",
          "reasoning": "NMR is broadly accepted in the field for studying binding modes and structural dynamics.",
          "next_step_or_outcome": "Functional evidence strength is Max PS3_supporting / Max BS3_supporting"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The A30P variant shows decreased lipid affinity compared to wild-type, which aligns with increased toxicity.",
          "judgment": "No",
          "reasoning": "The paper does not provide statistical analyses (e.g., p-values, OddsPath) for this variant.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study compares wild-type and variants but does not specify the number of control variants used.",
          "judgment": "10 or less",
          "reasoning": "The study includes wild-type and three variants (A30P, E46K, A53T), totaling 4 controls.",
          "next_step_or_outcome": "Functional evidence strength is Max PS3_supporting"
        }
      ],
      "final_strength": "PS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "E",
          "alt": "K",
          "position": "46"
        },
        "variant_string_id": "SNCA E46K"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The classic manifestation of familial and sporadic PD is the formation of fibrillar structures of RS, which accumulate as the main component in intraneuronal Lewy bodies.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism is directly tied to RS misfolding and aggregation."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses solution NMR to analyze phospholipid binding modes of RS variants.",
          "judgment": "Yes",
          "reasoning": "Phospholipid binding is central to RS function and misfolding-related pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The study compares variants to wild-type RS and references previous biophysical studies.",
          "judgment": "No",
          "reasoning": "Replicates and control variant details are not explicitly stated.",
          "next_step_or_outcome": "Proceed to Sub-step 3b"
        },
        {
          "step_name": "Sub-step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "Solution NMR is a standard technique in structural biology.",
          "judgment": "Yes",
          "reasoning": "NMR is broadly accepted for studying binding modes.",
          "next_step_or_outcome": "Functional evidence strength is Max PS3_supporting / Max BS3_supporting"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The E46K variant shows increased lipid binding compared to wild-type, linked to elevated SL1 binding mode and toxicity.",
          "judgment": "No",
          "reasoning": "No statistical analysis or OddsPath provided.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study includes 4 control variants (wild-type + A30P, E46K, A53T).",
          "judgment": "10 or less",
          "reasoning": "Total controls are insufficient for moderate strength.",
          "next_step_or_outcome": "Functional evidence strength is Max PS3_supporting"
        }
      ],
      "final_strength": "PS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "53"
        },
        "variant_string_id": "SNCA A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The classic manifestation of familial and sporadic PD is the formation of fibrillar structures of RS, which accumulate as the main component in intraneuronal Lewy bodies.",
          "judgment": "Yes",
          "reasoning": "RS misfolding and aggregation are central to PD pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses solution NMR to analyze phospholipid binding modes of RS variants.",
          "judgment": "Yes",
          "reasoning": "Phospholipid binding is critical to RS function and misfolding.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The study compares variants to wild-type RS and references previous biophysical studies.",
          "judgment": "No",
          "reasoning": "Replicates and control variant details are not explicitly stated.",
          "next_step_or_outcome": "Proceed to Sub-step 3b"
        },
        {
          "step_name": "Sub-step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "Solution NMR is a standard technique in structural biology.",
          "judgment": "Yes",
          "reasoning": "NMR is broadly accepted for studying binding modes.",
          "next_step_or_outcome": "Functional evidence strength is Max PS3_supporting / Max BS3_supporting"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The A53T variant shows comparable lipid binding to wild-type but elevated SL1 binding mode, linked to increased toxicity.",
          "judgment": "No",
          "reasoning": "No statistical analysis or OddsPath provided.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study includes 4 control variants (wild-type + A30P, E46K, A53T).",
          "judgment": "10 or less",
          "reasoning": "Total controls are insufficient for moderate strength.",
          "next_step_or_outcome": "Functional evidence strength is Max PS3_supporting"
        }
      ],
      "final_strength": "PS3_supporting"
    }
  ]
}